These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36052079)

  • 21. [The role of nuclear receptor transcription factor NR2F6 in tumor].
    Huang L; Liu J; Zhu Y; Zhou Q; Xiao B; Sun Z; Li L
    Sheng Wu Gong Cheng Xue Bao; 2021 Aug; 37(8):2595-2602. PubMed ID: 34472280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B1b cells recognize protective antigens after natural infection and vaccination.
    Cunningham AF; Flores-Langarica A; Bobat S; Dominguez Medina CC; Cook CN; Ross EA; Lopez-Macias C; Henderson IR
    Front Immunol; 2014; 5():535. PubMed ID: 25400633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Origin of CD5+ B cells and natural IgM-secreting cells: reconstitution potential of adult bone marrow, spleen and peritoneal cells.
    Thomas-Vaslin V; Coutinho A; Huetz F
    Eur J Immunol; 1992 May; 22(5):1243-51. PubMed ID: 1374338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-1b Cells Possess Unique bHLH-Driven P62-Dependent Self-Renewal and Atheroprotection.
    Pattarabanjird T; Marshall M; Upadhye A; Srikakulapu P; Garmey JC; Haider A; Taylor AM; Lutgens E; McNamara CA
    Circ Res; 2022 Apr; 130(7):981-993. PubMed ID: 35209718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond CTLA-4 and PD-1: Orphan nuclear receptor NR2F6 as T cell signaling switch and emerging target in cancer immunotherapy.
    Klepsch V; Hermann-Kleiter N; Baier G
    Immunol Lett; 2016 Oct; 178():31-6. PubMed ID: 26992368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell-independent immune responses do not require CXC ligand 13-mediated B1 cell migration.
    Colombo MJ; Sun G; Alugupalli KR
    Infect Immun; 2010 Sep; 78(9):3950-6. PubMed ID: 20584971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of the orphan nuclear receptor NR2F6 enhances CD8
    Jakic B; Olson WJ; Siegmund K; Klepsch V; Kimpel J; Labi V; Zehn D; Baier G; Hermann-Kleiter N
    Cell Death Dis; 2021 Feb; 12(2):187. PubMed ID: 33589606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of B1 and marginal zone B cells during ovarian cancer.
    Maslanka J; Torres G; Londregan J; Goldman N; Silberman D; Somerville J; Riggs JE
    Cell Immunol; 2024; 395-396():104788. PubMed ID: 38000306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanoma-intrinsic NR2F6 activity regulates antitumor immunity.
    Kim H; Feng Y; Murad R; Pozniak J; Pelz C; Chen Y; Dalal B; Sears R; Sergienko E; Jackson M; Ruppin E; Herlyn M; Harris C; Marine JC; Klepsch V; Baier G; Ronai ZA
    Sci Adv; 2023 Jul; 9(27):eadf6621. PubMed ID: 37406115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of the orphan nuclear receptor NR2F6 is associated with improved survival across molecular subgroups in endometrial cancer patients.
    Proppe L; Jagomast T; Beume S; Klapper L; Gitas G; Köster F; Perner S; Rody A; Ribbat-Idel J; Hanker LC
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7155-7164. PubMed ID: 36884115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma Cell Alloantigen 1 and IL-10 Secretion Define Two Distinct Peritoneal B1a B Cell Subsets With Opposite Functions, PC1
    Schumacher A; Ehrentraut S; Scharm M; Wang H; Hartig R; Morse HC; Zenclussen AC
    Front Immunol; 2018; 9():1045. PubMed ID: 29868008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear orphan receptor NR2F6 as a safeguard against experimental murine colitis.
    Klepsch V; Gerner RR; Klepsch S; Olson WJ; Tilg H; Moschen AR; Baier G; Hermann-Kleiter N
    Gut; 2018 Aug; 67(8):1434-1444. PubMed ID: 28779026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A proteomic analysis reveals that Snail regulates the expression of the nuclear orphan receptor Nuclear Receptor Subfamily 2 Group F Member 6 (Nr2f6) and interleukin 17 (IL-17) to inhibit adipocyte differentiation.
    Peláez-García A; Barderas R; Batlle R; Viñas-Castells R; Bartolomé RA; Torres S; Mendes M; Lopez-Lucendo M; Mazzolini R; Bonilla F; García de Herreros A; Casal JI
    Mol Cell Proteomics; 2015 Feb; 14(2):303-15. PubMed ID: 25505127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different IgM
    Granja AG; Tafalla C
    Fish Shellfish Immunol; 2019 Feb; 85():9-17. PubMed ID: 28989090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sphingosine 1-phosphate regulates peritoneal B-cell trafficking for subsequent intestinal IgA production.
    Kunisawa J; Kurashima Y; Gohda M; Higuchi M; Ishikawa I; Miura F; Ogahara I; Kiyono H
    Blood; 2007 May; 109(9):3749-56. PubMed ID: 17234743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A differentiation pathway for B1 cells in adult bone marrow.
    Esplin BL; Welner RS; Zhang Q; Borghesi LA; Kincade PW
    Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5773-8. PubMed ID: 19307589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of B1 and B2 lymphocytes in placental ischemia-induced hypertension.
    Laule CF; Odean EJ; Wing CR; Root KM; Towner KJ; Hamm CM; Gilbert JS; Fleming SD; Regal JF
    Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H732-H742. PubMed ID: 31397167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear orphan receptor NR2F6 directly antagonizes NFAT and RORγt binding to the Il17a promoter.
    Hermann-Kleiter N; Meisel M; Fresser F; Thuille N; Müller M; Roth L; Katopodis A; Baier G
    J Autoimmun; 2012 Dec; 39(4):428-40. PubMed ID: 22921335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nuclear orphan receptor NR2F6 suppresses lymphocyte activation and T helper 17-dependent autoimmunity.
    Hermann-Kleiter N; Gruber T; Lutz-Nicoladoni C; Thuille N; Fresser F; Labi V; Schiefermeier N; Warnecke M; Huber L; Villunger A; Eichele G; Kaminski S; Baier G
    Immunity; 2008 Aug; 29(2):205-16. PubMed ID: 18701084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
    Li H; Zhang W; Niu C; Lin C; Wu X; Jian Y; Li Y; Ye L; Dai Y; Ouyang Y; Chen J; Qiu J; Song L; Zhang Y
    Int J Cancer; 2019 Oct; 145(7):1921-1934. PubMed ID: 30895619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.